Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21774708 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study Comparing Doxorubicin, Bleomycin,Vinblastine, Dacarbazine (ABVD) vs Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine and Prednisone (BEACOPP)
Condition: Hodgkin Lymphoma
Interventions: Drug: Bleomycin;   Drug: Etoposide;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Procarbazine;   Drug: Prednisone;   Drug: Vinblastine;   Drug: Dacarbazine

Indicates status has not been verified in more than two years